Clinically guided adjustment of sorafenib daily dose is advisable for cirrhotics patients with hepatocellular carcinoma (HCC). (15th February 2015)

Record Type:: Journal Article
Title:: Clinically guided adjustment of sorafenib daily dose is advisable for cirrhotics patients with hepatocellular carcinoma (HCC). (15th February 2015)
Main Title:: Clinically guided adjustment of sorafenib daily dose is advisable for cirrhotics patients with hepatocellular carcinoma (HCC)
Authors:: Gallusi, G.
De Santis, A.
Iegri, C.
Lupo, M.
Mascolo, A.
Attili, A.F.
Abstract:
Is Part Of:: Digestive and liver disease. Volume 47(2015)Supplement 1
Journal:: Digestive and liver disease
Issue:: Volume 47(2015)Supplement 1
Issue Display:: Volume 47, Issue 1 (2015)
Year:: 2015
Volume:: 47
Issue:: 1
Issue Sort Value:: 2015-0047-0001-0000
Page Start:: e34
Page End:
Publication Date:: 2015-02-15
Subjects:: Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
616.33005
Journal URLs:: http://www.sciencedirect.com/science/journal/15908658 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.dld.2015.01.076 ↗
Languages:: English
ISSNs:: 1590-8658
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3588.345600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 5435.xml